{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:09:23Z","timestamp":1778670563552,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2023R1A2C2003034"],"award-info":[{"award-number":["2023R1A2C2003034"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9G1014520"],"award-info":[{"award-number":["NRF-2022M3A9G1014520"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150581","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:24:15Z","timestamp":1769531055000},"page":"150581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deep learning-guided discovery of IL23\/IL23R macromolecular inhibitors: An integrative framework combining virtual screening and experimental validation"],"prefix":"10.1016","volume":"346","author":[{"given":"Abdul","family":"Manan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Qayyum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajath","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150581_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"Interleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0010","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/rheumatology\/keab461","article-title":"Interleukin-23 in perspective","volume":"60","author":"Sherlock","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10067-013-2469-y","article-title":"Involvement of IL-23 in Enteropathic arthritis patients with inflammatory bowel disease: preliminary results","volume":"33","author":"Gheita","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(19)31513-2","article-title":"Interleukin-23 blockade: another breakthrough in the treatment of psoriasis","volume":"394","author":"Lebwohl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.12840","article-title":"Interleukin-23 pathway at the Enthesis: the emerging story of Enthesitis in Spondyloarthropathy","volume":"294","author":"Bridgewood","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2018.03.144","article-title":"Interleukin-23 promotes the migration and invasion of gastric Cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway","volume":"499","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ibd.20894","article-title":"Interleukin-23\/Th17 pathways and inflammatory bowel disease","volume":"15","author":"Abraham","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 Axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/14712598.2024.2401148","article-title":"The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target","volume":"24","author":"Su","year":"2024","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0050","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CCID.S364640","article-title":"Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: a review of the real-world evidence","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/CCID.S462797","article-title":"The role of interleukin 23\/17 Axis in psoriasis management: a comprehensive review of clinical trials","volume":"17","author":"Potestio","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ced.14979","article-title":"Anti-interleukin-23 for psoriasis in elderly patients: Guselkumab, Risankizumab and Tildrakizumab in real-world practice","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/jpet.119.258046","article-title":"Inhibition of Interleukin-23\u2013mediated inflammation with a novel small molecule inverse agonist of ROR\u03b3t","volume":"371","author":"Gauld","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/antib13030076","article-title":"Therapeutic advances in psoriasis: from biologics to emerging Oral small molecules","volume":"13","author":"Ferrara","year":"2024","journal-title":"Antibodies"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0075","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1021\/acs.chemrev.4c00469","article-title":"At the interface: small-molecule inhibitors of soluble cytokines","volume":"125","author":"Raavi","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/OARRR.S363736","article-title":"Tofacitinib inhibits STAT phosphorylation and matrix Metalloproteinase-3, \u22129 and \u221213 production by C28\/I2 human juvenile chondrocytes","volume":"14","author":"Thorpe","year":"2022","journal-title":"Open Access Rheumatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738481","article-title":"Tofacitinib suppresses several JAK-STAT pathways in rheumatoid arthritis in vivo and baseline signaling profile associates with treatment response","volume":"12","author":"Palmroth","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2014-207201","article-title":"Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors","volume":"75","author":"Gao","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106642","article-title":"Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis","volume":"189","author":"Roskoski","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0100","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.drudis.2021.05.019","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0105","doi-asserted-by":"crossref","first-page":"13664","DOI":"10.1039\/D1SC04444C","article-title":"Structure-based de novo drug design using 3D deep generative models","volume":"12","author":"Li","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0110","series-title":"Structure-Aware Generation of Drug-Like Molecules","author":"Drot\u00e1r","year":"2021"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0115","article-title":"Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components","volume":"23","author":"Zhang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0120","doi-asserted-by":"crossref","first-page":"12166","DOI":"10.1039\/D3SC04091G","article-title":"A flexible data-free framework for structure-based de novo drug design with reinforcement learning","volume":"14","author":"Du","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0125","first-page":"796","article-title":"Gotta be SAFE: a new framework for molecular design","volume":"3","author":"Noutahi","year":"2024","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0130","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/bioinformatics\/btaa1005","article-title":"DeepPurpose: a deep learning library for drug\u2013target interaction prediction","volume":"36","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.immuni.2017.12.008","article-title":"Structural activation of pro-inflammatory human cytokine IL-23 by cognate IL-23 receptor enables recruitment of the shared receptor IL-12R\u03b21","volume":"48","author":"Bloch","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0140","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17460441.2019.1581170","article-title":"DataWarrior: an evaluation of the open-source drug discovery tool","volume":"14","author":"L\u00f3pez-L\u00f3pez","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0150","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0155","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0160","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144652","article-title":"A hybrid protocol for peptide development: integrating deep generative models and physics simulations for biomolecular design targeting IL23R\/IL23","volume":"316","author":"Qayyum","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0180","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of <scp>IL<\/Scp> \u221223 and the <scp>IL<\/Scp> \u221223\/ <scp> T H <\/Scp> 17 immune Axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0185","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jid.2023.04.019","article-title":"IL-23\/IL-23R promote macrophage pyroptosis and T helper 1\/T helper 17 cell differentiation in mycobacterial infection","volume":"143","author":"Wang","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0190","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3390\/cells9092044","article-title":"Decoding IL-23 signaling Cascade for new therapeutic opportunities","volume":"9","author":"Pastor-Fern\u00e1ndez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128229","article-title":"Small molecule approaches to treat autoimmune and inflammatory diseases (part III): targeting cytokines and cytokine receptor complexes","volume":"48","author":"Zheng","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0200","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/s41467-023-38541-2","article-title":"Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes","volume":"14","author":"Lay","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/biology14040347","article-title":"The role of IL-23 in the development of inflammatory diseases","volume":"14","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0210","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1021\/acs.jcim.6b00039","article-title":"Motions of allosteric and Orthosteric ligand-binding sites in proteins are highly correlated","volume":"56","author":"Ma","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2026.150581_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.652121","article-title":"Allosterism vs. orthosterism: recent findings and future perspectives on A2B AR physio-pathological implications","volume":"12","author":"Barresi","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026005076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026005076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:15:37Z","timestamp":1778667337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026005076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0141813026005076"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150581","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning-guided discovery of IL23\/IL23R macromolecular inhibitors: An integrative framework combining virtual screening and experimental validation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150581"}}